Codexis, Inc.

CDXS Healthcare Biotechnology

Codexis, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $70.4 million, up 18.6% from fiscal 2024. In the quarter to June 2026, revenue fell 2.69%, EPS grew 18.8%, free cash flow grew 48.6% and total debt fell 14.1%, each against the same quarter a year earlier.

1.25 0.11 −8.09%
Market cap
$148.9M
P/E
0.0×
Fwd P/E
−6.6×
Dividend yield
—
F-score
4/9
Altman Z
−4.75
Beneish M
−3.57
Dividend safety
n/a

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
Cash and Short Term Investments
19.24 31.22 53.04 91.16 150.76 117.38 114.51 65.64 73.96 78.69
Receivables
5.92 11.80 13.47 19.13 24.76 33.10 38.76 19.11 14.51 10.19
Inventory
0.83 1.04 0.59 0.37 0.96 1.16 2.03 2.69 1.80 1.82
Other current assets
1.24 0.98 0.04 1.03 4.53 4.56 2.12 0.82 4.38 0.49
Total current assets
27.23 45.04 68.20 114.21 184.42 161.89 162.89 93.47 98.77 96.82
Property, Plant, Equpment (Net)
2.16 2.82 4.76 6.28 9.68 21.35 22.61 15.49 14.20 13.02
Long-Term Investments
1.14 0.67 0.59 1.06 1.45 14.00 20.51 9.70 2.80 2.50
Goodwill and Intangible Assets (Total)
3.24 3.24 3.24 3.24 3.24 3.24 3.24 2.46 2.46 2.46
Long-term assets (Other)
1.88 1.86 2.50 1.24 1.36 1.80 1.87 2.31 2.08 2.50
Total non-current assets
8.42 8.59 11.09 34.87 37.22 84.50 87.50 43.10 50.24 50.98
Total Assets
35.65 53.63 79.28 149.07 221.65 246.38 250.39 136.56 149.01 147.80
Accounts Payable
4.23 3.55 3.05 2.62 2.97 3.00 3.25 5.95 2.84 1.55
Accrued Expenses
4.31 4.75 5.27 5.00 7.29 11.12 11.45 11.25 11.41 11.04
Current Part of Capital Lease
— — — 0.06 — — — — — —
Current Revenue (Deferred)
1.71 12.29 4.94 0.06 1.82 2.59 13.73 10.12 0.35 7.01
Other current liabilities
2.11 4.36 4.86 6.54 10.27 12.58 15.28 4.74 6.22 2.77
Total current liabilities
12.37 24.95 18.11 15.39 24.98 33.37 49.07 35.83 23.65 25.32
Long Term Debt (Total)
0.89 0.76 0.10 24.95 22.32 43.56 38.28 — 28.91 40.11
Non-current Revenue (Deferred)
1.07 1.50 3.35 1.99 2.97 3.75 16.88 0.64 0.10 0.36
Non-current Liabilities (Other)
2.23 1.86 1.42 1.23 1.27 1.31 1.37 1.23 1.27 1.33
Total non-current liabilities
4.18 4.13 4.86 28.17 26.56 48.62 56.53 14.12 58.44 71.95
Total liabilities
16.55 29.08 22.98 43.56 51.54 81.99 105.60 49.95 82.08 97.27
Additional Paid In Capital
311.16 340.08 386.78 447.92 536.52 552.08 566.08 584.14 629.67 657.29
Common Stock (Net)
0.00 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01
Retained Earnings
(292.07) (315.06) (330.47) (342.41) (366.42) (387.70) (421.29) (497.53) (562.81) (606.78)
Common Equity (Total)
19.10 24.55 56.31 105.52 170.10 164.39 144.80 86.62 66.93 50.53
Shareholders Equity (Total)
19.10 24.55 56.31 105.52 170.10 164.39 144.80 86.62 66.93 50.53
Shareholders Equity and Liabilities (Total)
35.65 53.63 79.28 149.07 221.65 246.38 250.39 136.56 149.01 147.80
Shares (Common)
41.26 48.37 54.07 58.88 64.28 65.11 65.81 69.91 81.85 90.48
Shareholders Equity (Tangible)
15.86 21.31 53.07 102.28 166.86 161.15 141.56 84.15 64.46 48.07
Net Debt
(18.35) (30.46) (52.94) (66.21) (128.43) (73.81) (76.23) (65.63) (45.06) (38.58)
Total Debt
0.89 0.76 0.10 24.95 22.32 43.56 38.28 — 28.91 40.11

Fold the line items

In millions of $ except per-share values · columns are period end dates